Dr. Han Dai is currently a Scientific Leader and GSK Fellow in Future Pipeline Discovery at GlaxoSmithKline and a GSK Visiting Professor at High Magnetic Field Laboratory (HMFL), Chinese Academy of Sciences (CAS). He has been working in the pharmaceutical industries for ~10 years, starting with responsibilities in protein chemistry, enzymology, biophysics & structural biology and expanding quickly into preclinical drug discovery program management and leadership, managing also cell biology, DMPK, and pharmacology aspects of programs. He has broad understanding of the discovery value chain from target validation to pre-clinical development and experiences in project leadership, managing collaboration of multidisciplinary matrix research teams within company and with external CROs, non-profit academic collaborators and risk-sharing partners. He has won a number of awards at GSK including several GSK Exceptional Science Awards and the most recent GSK Recognition Award for multiple Clinical Candidate Selections. He has published more than 40 papers, book chapter, abstracts and patents in reputable journals (including Nature Communications, Nature Structural and Molecular Biology, Science, Cell), and conferences, serving as the first and corresponding author, a frequently invited journal reviewer, an editorial board member for several journals, and an invited speaker at international conferences. Han is actively involved in community services, including GSK Alternative Discovery & Development Communications and Engagement, GSK R&D Data Science Matrix Group, LRIG Philadelphia Steering Committee, the Adhesion GPCR Consortium as an Associate Member and F1000 Drug Discovery & Design Section as a Full Faculty Member. Han also serves as previously the Vice President of Business Development and currently the President-Elect of Sino-American Pharmaceutical Professional Association ¨C Greater Philadelphia (SAPA-GP) and an Executive Council member of Sino-American Pharmaceutical Professional Association (SAPA). Han completed his Bachelor of Science in Department for Intensive Instructions at Nanjing University in Nanjing, China, his Ph.D. at UT Southwestern Medical Center at Dallas as a Frank and Sara McKnight fellow, his postdoctoral training in Harvard Medical School as a Helen Hay Whitney fellow.